Collectively, the findings of this study indicate that monitoring tumor infiltration by ICAM-1+CD8+ T cells using ICAM-1-targeted noninvasive imaging provides a novel means to develop effective RT combination therapies and increases the frequency of the abscopal effect in clinical settings. This evidence concerns the gene CD8A and neoplasm.